120 related articles for article (PubMed ID: 33054031)
21. Comparative study of immunohistochemical expression of ERG and MAGI2 in prostatic carcinoma.
Dawoud MM; Aiad HA; Bahbah AMNH; Shaban MI
Ann Diagn Pathol; 2021 Jun; 52():151727. PubMed ID: 33713943
[TBL] [Abstract][Full Text] [Related]
22. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation.
Wang W; Bergh A; Damber JE
APMIS; 2009 Mar; 117(3):185-95. PubMed ID: 19245591
[TBL] [Abstract][Full Text] [Related]
23. Transgenic mouse with human mutant p53 expression in the prostate epithelium.
Elgavish A; Wood PA; Pinkert CA; Eltoum IE; Cartee T; Wilbanks J; Mentor-Marcel R; Tian L; Scroggins SE
Prostate; 2004 Sep; 61(1):26-34. PubMed ID: 15287091
[TBL] [Abstract][Full Text] [Related]
24. p63 cytoplasmic aberrance is associated with high prostate cancer stem cell expression.
Ferronika P; Triningsih FX; Ghozali A; Moeljono A; Rahmayanti S; Shadrina AN; Naim AE; Wudexi I; Arnurisa AM; Nanwani ST; Harijadi A
Asian Pac J Cancer Prev; 2012; 13(5):1943-8. PubMed ID: 22901151
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
26. Significance of p53 and ki-67 expression in prostate cancer.
Verma R; Gupta V; Singh J; Verma M; Gupta G; Gupta S; Sen R; Ralli M
Urol Ann; 2015; 7(4):488-93. PubMed ID: 26692671
[TBL] [Abstract][Full Text] [Related]
27. Deletion of NKX3.1 via CRISPR/Cas9 Induces Prostatic Intraepithelial Neoplasia in C57BL/6 Mice.
Park JJ; Kim JE; Jeon Y; Lee MR; Choi JY; Song BR; Park JW; Kang MJ; Choi HJ; Bae SJ; Lee H; Kang BC; Hwang DY
Technol Cancer Res Treat; 2020; 19():1533033820964425. PubMed ID: 33094683
[TBL] [Abstract][Full Text] [Related]
28. Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer.
Amirghofran Z; Monabati A; Gholijani N
Pathol Oncol Res; 2004; 10(1):37-41. PubMed ID: 15029260
[TBL] [Abstract][Full Text] [Related]
29. [Expression of nuclear Ki-67 antigen in prostatic high grade intraepithelial neoplasia and prostatic carcinoma].
Veliiković LJ; Dordević B; Rancić G; Marjanović G
Vojnosanit Pregl; 2007 May; 64(5):325-30. PubMed ID: 17585548
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of Ki-67, p53, and Bcl-2 expression in prostate cancer patients with lymph node metastases: a retrospective immunohistochemical analysis.
Masuda M; Takano Y; Iki M; Asakura T; Hashiba T; Noguchi S; Hosaka M
Pathol Int; 1998 Jan; 48(1):41-6. PubMed ID: 9589463
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery.
Stapleton AM; Zbell P; Kattan MW; Yang G; Wheeler TM; Scardino PT; Thompson TC
Cancer; 1998 Jan; 82(1):168-75. PubMed ID: 9428494
[TBL] [Abstract][Full Text] [Related]
32. Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy.
Moul JW
Eur Urol; 1999; 35(5-6):399-407. PubMed ID: 10325496
[TBL] [Abstract][Full Text] [Related]
33. Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia.
Zhong W; Peng J; He H; Wu D; Han Z; Bi X; Dai Q
Clin Invest Med; 2008; 31(1):E8-E15. PubMed ID: 18312749
[TBL] [Abstract][Full Text] [Related]
34. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations.
Shibata MA; Ward JM; Devor DE; Liu ML; Green JE
Cancer Res; 1996 Nov; 56(21):4894-903. PubMed ID: 8895741
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Factors of Prostate Cancer in Tunisian Men: Immunohistochemical Study.
Missaoui N; Abdelkarim SB; Mokni M; Hmissa S
Asian Pac J Cancer Prev; 2016; 17(5):2655. PubMed ID: 27268646
[TBL] [Abstract][Full Text] [Related]
36. Ki-67 and ProExC are useful immunohistochemical markers in esophageal squamous intraepithelial neoplasia.
Wang WC; Wu TT; Chandan VS; Lohse CM; Zhang L
Hum Pathol; 2011 Oct; 42(10):1430-7. PubMed ID: 21420715
[TBL] [Abstract][Full Text] [Related]
37. ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21.
Cosi I; Pellecchia A; De Lorenzo E; Torre E; Sica M; Nesi G; Notaro R; De Angioletti M
J Hematol Oncol; 2020 Aug; 13(1):112. PubMed ID: 32791988
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of global DNA hypomethylation in human prostate cancer and prostatic intraepithelial neoplasm tissues by immunohistochemistry.
Yang B; Sun H; Lin W; Hou W; Li H; Zhang L; Li F; Gu Y; Song Y; Li Q; Zhang F
Urol Oncol; 2013 Jul; 31(5):628-34. PubMed ID: 21704537
[TBL] [Abstract][Full Text] [Related]
39. Ki-67 immunolabeling in pre-malignant lesions and carcinoma of the prostate. Histological correlation and prognostic evaluation.
Muñoz E; Gómez F; Paz JI; Casado I; Silva JM; Corcuera MT; Alonso MJ
Eur J Histochem; 2003; 47(2):123-8. PubMed ID: 12777207
[TBL] [Abstract][Full Text] [Related]
40. Immunoexpression of estrogen receptor-β and progesterone receptor in prostate adenocarcinoma, does it inhibit neoplastic proliferation and invasion?
Bera KN; Yadav SK; Prakash O; Singh S; Sarin N
Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S30-S33. PubMed ID: 32108623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]